A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)
PHASE2
Investigators are trying to find better treatments for people with HIV-1. I...
Status
Active Not Recruiting
Location
Zuckerberg San Francisco General Hospital and Trauma Center ( Site 4107)
Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]
PHASE2
This is a randomized, controlled, double-blind, study to evaluate the safet...
Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)
PHASE1
The study will evaluate the safety, tolerability, pharmacokinetics, and ant...